Opana
Product Images NDC 16590-767

6 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Opana (NDC 16590-767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chart_fig1 (Figure 1)

Chart_fig1 (Figure 1)
A line chart comparing the percentage of patients improved against the percent of reduction/improvement in pain for Oxymorphone ER and placebo. The chart shows a higher percentage of patient improvement with Oxymorphone ER across various levels of pain reduction compared to placebo.*
FDA Label Image

Chart_fig2 (Figure 2)

Chart_fig2 (Figure 2)
A line graph comparing the percentage of patients improved by the percent reduction or improvement in pain for Oxymorphone ER versus placebo. The x-axis represents percent reduction in pain from >0 to 100%, and the y-axis shows the percentage of patients improved, declining for both groups as the percent reduction increases, with Oxymorphone ER showing higher percentages than placebo.*
FDA Label Image

Label Image 10mg (Opana Er 10mg Label)

Label Image 10mg (Opana Er 10mg Label)
OPANA ER 10 mg tablet bottle label from STAT RX USA LLC, containing 90 tablets. The label states it is a generic form of Oxymorphone Hydrochloride extended-release 10 mg, manufactured by Endo Pharmaceuticals Inc., with storage instructions between 59-86 degrees Fahrenheit. The label also includes a National Drug Code (NDC) and warnings to keep out of reach of children.*
FDA Label Image

Label Image 40mg (Opana Er 40mg Label)

Label Image 40mg (Opana Er 40mg Label)
OPANA ER 40 mg extended-release tablets packaging label showing 30 count, labeled by STAT RX USA LLC. The label includes the National Drug Code (NDC) 16590-609-30, active ingredient Oxymorphone Hydrochloride 40 mg, and manufacturer Endo Pharmaceuticals Inc. Location details and a caution about controlled substance laws are also present.*
FDA Label Image

Label Image 5mg (Opana Er 5mg Label)

Label Image 5mg (Opana Er 5mg Label)
OPANA ER C-II 5 mg tablet bottle label showing 56 tablets, labeled as oxymorphone hydrochloride extended-release. Packaged and distributed by STAT RX USA LLC in Gainesville, GA. Manufactured by Endo Pharmaceuticals Inc., Chadds Ford, PA. Includes a National Drug Code (NDC) 16590-767-56 and storage instructions to keep between 59-86 degrees F.*
FDA Label Image

Structure Image (Opana Er Struct)

Structure Image (Opana Er Struct)
Chemical structure of the active ingredient in OPANA ER, showing the molecular arrangement including hydroxyl (OH) groups, methyl (CH3) group, and hydrochloride (HCl) component, depicting its detailed chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.